Literature DB >> 15740962

Risk factors for hemorrhage-related reexploration and blood transfusion after conventional versus coronary revascularization without cardiopulmonary bypass.

Timothy L Frankel1, Sotiris C Stamou, Robert C Lowery, Emmanouil I Kapetanakis, Peter C Hill, Elizabeth Haile, Paul J Corso.   

Abstract

OBJECTIVE: The premise of coronary revascularization without cardiopulmonary bypass (off-pump CABG) proposes that patient morbidity and, potentially, mortality can be reduced without compromising the excellent results of conventional revascularization techniques (on-pump CABG). It is unknown, however, whether coronary artery bypass without cardiopulmonary bypass (off-pump CABG) is associated with similar hemorrhage related reexploration rates and blood transfusion requirements compared to the on-pump approach.
METHODS: Between January 1998 and June 2002, 3646 patients underwent off-pump CABG and were compared with a contemporaneous control group of 5197 on-pump CABG patients. A logistic regression model was used to test the difference in the postoperative hemorrhage related reexploration rates and need for postoperative blood transfusions between the groups, controlling for preoperative risk factors. The patients undergoing off-pump CABG were matched to on-pump patients by propensity score.
RESULTS: Hemorrhage related reexploration rates were comparable between the 2 groups (odds-ratio [OR]=0.80, 95% confidence intervals [CI]=0.55-1.09, P=0.15). Off-pump CABG was associated with a lower need for single and multiple unit postoperative blood transfusions (OR=0.30, CI=0.24-0.31, P<0.01 and OR=0.4, CI=0.36-0.51, P<0.01, respectively) compared to on-pump CABG patients.
CONCLUSIONS: Off-pump CABG eliminates the risks of cardiopulmonary bypass and the systemic inflammatory response it elicits. A substantially lower need for postoperative blood transfusions and a comparable hemorrhage-related reexploration rate suggests that off-pump CABG may avoid the morbidity and mortality associated with excessive postoperative blood loss.

Entities:  

Mesh:

Year:  2004        PMID: 15740962     DOI: 10.1016/j.ejcts.2004.11.021

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  10 in total

1.  Bleeding-associated outcomes with preoperative clopidogrel use in on- and off-pump coronary artery bypass.

Authors:  Jeffrey S Berger; Peter M Herout; Qing Harshaw; Steven R Steinhubl; Carla B Frye; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

Review 2.  Off-Pump Coronary Artery Bypass Grafting; is it Still Relevant?

Authors:  Chima K P Ofoegbu; Rodgers M Manganyi
Journal:  Curr Cardiol Rev       Date:  2022

3.  Prothrombin complex concentrate mitigates diffuse bleeding after cardiopulmonary bypass in a porcine model.

Authors:  F Kaspereit; S Hoffmann; I Pragst; G Dickneite
Journal:  Br J Anaesth       Date:  2010-08-17       Impact factor: 9.166

4.  The impact of blood use on patients undergoing coronary artery bypass surgery: a prospective study.

Authors:  A Lako; S Bilali; S Memishaj; A Daka; T Dedej; T Nurka; V Bilali; V Gjylameti
Journal:  G Chir       Date:  2014 Jan-Feb

5.  The influence of hypothermia on transfusion requirement in patients who received clopidogrel in proximity to off-pump coronary bypass surgery.

Authors:  Bo Ra Lee; Jong Wook Song; Young Lan Kwak; Kyoung Jong Yoo; Jae Kwang Shim
Journal:  Yonsei Med J       Date:  2014-01       Impact factor: 2.759

6.  Effect of Off-Pump Coronary Artery Bypass Surgery on Patients' Quality of Life.

Authors:  Mohammadhosain Afrand; Seyed Khalil Froozan-Nia; Hamide Dehghani; Mehrdad Jalalian; Mohammadtaghi Sarebanhassanabadi
Journal:  Cardiol Res       Date:  2014-02-27

7.  MiR-223 levels predicting perioperative bleeding in off-pump coronary artery bypass grafting.

Authors:  Zi Wang; Limin Xia; Qing Xu; Qiuyi Ji; Zhifeng Yao; Qianzhou Lv
Journal:  Ann Transl Med       Date:  2020-11

8.  Tranexamic Acid Administered During Off-Pump Coronary Artery Bypass Graft Surgeries Achieves Good Safety Effects and Hemostasis.

Authors:  Enshi Wang; Xin Yuan; Yang Wang; Weinan Chen; Xingtong Zhou; Shengshou Hu; Su Yuan
Journal:  Front Cardiovasc Med       Date:  2022-02-04

9.  Evaluation of Plasma Fibrinogen Levels before and after Coronary Artery Bypass Graft Surgery and Its Association with the Need for Blood Products.

Authors:  Azim Honarmand; Keivan Bagheri; Alireza Hoghooghy; Kazem Rezaei
Journal:  Adv Biomed Res       Date:  2022-03-30

10.  Predictors of packed red cell transfusion after isolated primary coronary artery bypass grafting--the experience of a single cardiac center: a prospective observational study.

Authors:  Elsayed M Elmistekawy; Lee Errett; Hosam F Fawzy
Journal:  J Cardiothorac Surg       Date:  2009-05-07       Impact factor: 1.637

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.